Form 4: Ironwood Pharmaceuticals Director Stock Grant

Duane R. Jon, a Director at Ironwood Pharmaceuticals Inc., received a grant of 63,481 shares of Class A Common Stock on June 16, 2026.

Summary

• Duane R. Jon, a Director at Ironwood Pharmaceuticals Inc. (IRWD), was granted 63,481 shares of Class A Common Stock on June 16, 2026.
• This grant was made under the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024.
• The restricted stock vests in full on the day before the annual stockholders' meeting for the following calendar year.
• Following this transaction, Mr. Jon beneficially owns 253,820 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine stock grant to a director as part of a compensation policy, with no immediate indication of positive or negative performance.

Positives

• Director Duane R. Jon received a significant grant of 63,481 shares of Class A Common Stock, indicating continued investment and alignment with the company's performance.
• The grant is part of a structured compensation policy for non-employee directors, suggesting a formalized approach to director remuneration.
• The vesting schedule aligns director incentives with longer-term company performance, as it vests before the next annual meeting.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a report of a stock grant to a director.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into stock ownership changes by company directors and officers. This specific filing details a stock grant to a director, a common practice in executive compensation to align incentives with shareholder value.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns director incentives with shareholder interests through stock ownership, but the immediate impact on share price is minimal as it's a compensation event.
• Employees: This filing does not directly impact employees, but reflects the company's compensation structure for its board.
• Management: The filing confirms a standard compensation practice for directors.

Next Steps

• The restricted stock vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Grant, Director Compensation, Ironwood Pharmaceuticals, IRWD, Beneficial Ownership